These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Pharmacokinetics of intrathecal chemotherapy and clinical problems]. Fujimoto T Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma. Ettinger LJ; Chervinsky DS; Freeman AI; Creaven PJ Cancer; 1982 Nov; 50(9):1676-82. PubMed ID: 6956429 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Balis FM; Blaney SM; McCully CL; Bacher JD; Murphy RF; Poplack DG Cancer Chemother Pharmacol; 2000; 45(3):259-64. PubMed ID: 10663645 [TBL] [Abstract][Full Text] [Related]
7. Current status of intrathecal chemotherapy for human meningeal neoplasms. Bleyer WA Natl Cancer Inst Monogr; 1977 Dec; 46():171-8. PubMed ID: 580638 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy administration directly into the fourth ventricle in a nonhuman primate model. Sandberg DI; Peet MM; Johnson MD; Cole P; Koru-Sengul T; Luqman AW J Neurosurg Pediatr; 2012 May; 9(5):530-41. PubMed ID: 22546032 [TBL] [Abstract][Full Text] [Related]
10. A primate model for study of methotrexate pharmacokinetics in the central nervous system. Poplack DG; Bleyer WA; Wood JH; Kostolich M; Savitch JL; Ommaya AK Cancer Res; 1977 Jul; 37(7 Pt 1):1982-5. PubMed ID: 405092 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methotrexate in the cerebrospinal fluid after intracerebroventricular administration in patients with meningeal carcinomatosis and altered cerebrospinal fluid flow dynamics. Miller KT; Wilkinson DS Ther Drug Monit; 1989; 11(3):231-7. PubMed ID: 2728081 [TBL] [Abstract][Full Text] [Related]
12. 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Mason WP; Yeh SD; DeAngelis LM Neurology; 1998 Feb; 50(2):438-44. PubMed ID: 9484369 [TBL] [Abstract][Full Text] [Related]
13. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723 [TBL] [Abstract][Full Text] [Related]
14. [Intraventricular chemotherapy for treatment of meningeal dissemination from malignant neoplasms (author's transl)]. Yamada K; Ushio Y; Hayakawa T; Mogami H; Bremer AM; West CR No Shinkei Geka; 1980 May; 8(5):443-7. PubMed ID: 7383259 [No Abstract] [Full Text] [Related]
15. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis. Mehta BM; Glass JP; Shapiro WR Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162 [TBL] [Abstract][Full Text] [Related]
16. Intrathecal chemotherapy with antineoplastic agents in children. Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696 [TBL] [Abstract][Full Text] [Related]
17. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates. Salzer W; Widemann B; McCully C; Adamson PC; Balis FM Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346 [TBL] [Abstract][Full Text] [Related]
18. Chronic ventricular cerebrospinal fluid sampling, drug injections, and pressure monitoring using subcutaneous reservoirs in monkeys. Wood JH; Poplack DG; Flor WJ; Gunby EN; Ommaya AK Neurosurgery; 1977; 1(2):132-5. PubMed ID: 98727 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Tetef ML; Margolin KA; Doroshow JH; Akman S; Leong LA; Morgan RJ; Raschko JW; Slatkin N; Somlo G; Longmate JA; Carroll MI; Newman EM Cancer Chemother Pharmacol; 2000; 46(1):19-26. PubMed ID: 10912573 [TBL] [Abstract][Full Text] [Related]